Identification of variants influences treatment decisions. Inhibitors of the poly-ADP-ribose polymerase (PARP) system, a pathway for repairing single-stranded DNA breaks, are recommended for tumors ...

AMPLITUDE is the first clinical trial to evaluate potential therapies for patients with mHSPC and known HRR gene alterations, with positive results supporting the niraparib-based combination regimen a ...

Dutasteride has long been a staple in the treatment of prostate-related health issues, prized for its efficacy in managing conditions that many face as they age. However, as with many potent ...

Junior research group leader Dr. Anne Fassl from the Department of Urology at Universitätsmedizin Frankfurt has been awarded a Young Investigator Award 2025 by the U.S.-based Prostate Cancer ...